Showing results (191-200 of 276) with videos related to
Sort By:
Pageof 28
Cancers|April 23, 2022
Noninvasive Physical Plasma as Innovative and Tissue-Preserving Therapy for Women Positive for Cervical Intraepithelial NeoplasiaJulia Marzi, Matthias B Stope, Melanie Henes, et al.Geburtshilfe Und Frauenheilkunde|December 1, 2018
Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast CancerVolkmar Müller, Achim Wöckel, Michael P Lux, et al.JMIR Research Protocols|June 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.Geburtshilfe Und Frauenheilkunde|June 1, 2019
Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert PanelHans-Christian Kolberg, Andreas Schneeweiss, Tanja N Fehm, et al.Archives of Gynecology and Obstetrics|December 23, 2017
Selecting living donors for uterus transplantation: lessons learned from two transplantations resulting in menstrual functionality and another attempt, aborted after organ retrievalSara Y Brucker, Mats Brännström, Florin-Andrei Taran, et al.Human Reproduction (Oxford, England)|February 17, 2026
Second report of registry of the International Society of Uterus Transplantation (ISUTx): international activities 2000-2024Mats Brännström, Catherine Racowsky, Johanna Wiik, et al.The Journal of Pathology|December 13, 2019
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasAlicia León-Castillo, Ester Gilvazquez, Remi Nout, et al.Diagnostics (Basel, Switzerland)|February 10, 2024
Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast TissueSelin Guergan, Bettina Boeer, Regina Fugunt, et al.JAMA Oncology|June 24, 2021
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical TrialThomas W P Friedl, Tanja Fehm, Volkmar Müller, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 23, 2024
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspectiveDavid Krug, Maggie Banys-Paluchowski, Sara Y Brucker, et al.Pageof 28